pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.

pH-sensitive polymeric nanoparticles are promising for oral drug delivery, especially for peptide/protein drugs and poorly water-soluble medicines. This review describes current status of pH-sensitive polymeric nanoparticles for oral drug delivery and introduces the mechanisms of drug release from them as well as possible reasons for absorption improvement, with emphasis on our contribution to this field. pH-sensitive polymeric nanoparticles are prepared mainly with polyanions, polycations, their mixtures or cross-linked polymers. The mechanisms of drug release are the result of carriers' dissolution, swelling or both of them at specific pH. The possible reasons for improvement of oral bioavailability include the following: improve drug stability, enhance mucoadhesion, prolong resident time in GI tract, ameliorate intestinal permeability and increase saturation solubility and dissolution rate for poorly water-soluble drugs. As for the advantages of pH-sensitive nanoparticles over conventional nanoparticles, we conclude that (1) most carriers used are enteric-coating materials and their safety has been approved. (2) The rapid dissolution or swelling of carriers at specific pH results in quick drug release and high drug concentration gradient, which is helpful for absorption. (3) At the specific pH carriers dissolve or swell, and the bioadhesion of carriers to mucosa becomes high because nanoparticles turn from solid to gel, which can facilitate drug absorption.

[1]  Qiang Zhang,et al.  A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 , 2012, International Journal of Nanomedicine.

[2]  H E Junginger,et al.  Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  Yuan-Man Hsu,et al.  Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori. , 2010, Biomacromolecules.

[4]  H. Sung,et al.  Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins. , 2011, Biomaterials.

[5]  L. Heinemann,et al.  Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. , 2001, Current pharmaceutical design.

[6]  T. E. Abraham,et al.  Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[7]  R. Gurny,et al.  Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. , 1995, Journal of pharmaceutical sciences.

[8]  Tao Zhang,et al.  Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Qiang Zhang,et al.  Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. , 2008, Journal of nanoscience and nanotechnology.

[10]  Qiang Zhang,et al.  A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  I. Chen,et al.  Biomedical nanoparticle carriers with combined thermal and magnetic responses , 2009 .

[12]  Youjia Cao,et al.  Multilayer nanoparticles with a magnetite core and a polycation inner shell as pH-responsive carriers for drug delivery. , 2010, Nanoscale.

[13]  Yifeng Pan,et al.  Acute oral toxicity evaluation of biodegradable and pH-sensitive hydrogel based on polycaprolactone, poly(ethylene glycol) and methylacrylic acid (MAA). , 2008, Journal of biomedical materials research. Part A.

[14]  Geert Verreck,et al.  Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. , 2007, International journal of pharmaceutics.

[15]  Jianhua Hu,et al.  Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  Qiang Zhang,et al.  Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. , 2011, International journal of pharmaceutics.

[17]  Bror Svarfvar,et al.  Drug Release from pH and Ionic Strength Responsive Poly(acrylic acid) Grafted Poly(vinylidenefluoride) Membrane Bags In Vitro , 2004, Pharmaceutical Research.

[18]  Ping Gao,et al.  Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations , 2004, Drug development and industrial pharmacy.

[19]  R. Gurny,et al.  pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs , 2001, AAPS PharmSci.

[20]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[21]  Jennifer M. Smith,et al.  Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. , 2005, Biomaterials.

[22]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[23]  J. Leroux,et al.  pH-sensitive unimolecular polymeric micelles: synthesis of a novel drug carrier. , 2003, Bioconjugate chemistry.

[24]  I. W. Cheong,et al.  Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Rainer H. Müller,et al.  Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .

[26]  S. Yuk,et al.  Temperature-induced gel formation of core/shell nanoparticles for the regeneration of ischemic heart. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Tse-Ying Liu,et al.  Novel pH-sensitive chitosan-based hydrogel for encapsulating poorly water-soluble drugs. , 2010, Acta biomaterialia.

[28]  Shirui Mao,et al.  Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. , 2007, International journal of pharmaceutics.

[29]  T. Yen,et al.  Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. , 2010, Biomaterials.

[30]  Qiang Zhang,et al.  Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer. , 2006, Journal of nanoscience and nanotechnology.

[31]  J. Fletcher Distribution , 2009, BMJ : British Medical Journal.

[32]  Qiang Zhang,et al.  pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. , 2004, International journal of pharmaceutics.

[33]  Jan Van Humbeeck,et al.  Influence of Preparation Methods on Solid State Supersaturation of Amorphous Solid Dispersions: A Case Study with Itraconazole and Eudragit E100 , 2010, Pharmaceutical Research.

[34]  P. Gao,et al.  Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs , 2006, Expert opinion on drug delivery.

[35]  A. Lamprecht,et al.  Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery. , 2006, International journal of pharmaceutics.

[36]  Qiang Zhang,et al.  Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. , 2007, International journal of pharmaceutics.

[37]  L. Mattoso,et al.  Preparation of chitosan nanoparticles using methacrylic acid. , 2008, Journal of colloid and interface science.

[38]  Hsin‐Lung Chen,et al.  Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. , 2010, Biomaterials.

[39]  Xuenong Zhang,et al.  Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats. , 2009, Die Pharmazie.

[40]  Qiang Zhang,et al.  Comprehensive studies on the interactions between chitosan nanoparticles and some live cells , 2011 .

[41]  Lichen Yin,et al.  Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. , 2009, Biomacromolecules.

[42]  F. Cakalagaoglu,et al.  Release behaviour and biocompatibility of drug-loaded pH sensitive particles. , 2006, International journal of pharmaceutics.

[43]  Hsing-Wen Sung,et al.  In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. , 2009, Biomaterials.

[44]  Yung-Chih Wu,et al.  A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Mohamed H. El-Shabouri,et al.  Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. , 2002, International journal of pharmaceutics.

[46]  T. E. Abraham,et al.  pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs. , 2007, International journal of pharmaceutics.

[47]  Qiang Zhang,et al.  Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics. , 2006, Journal of nanoscience and nanotechnology.

[48]  Lisa Brannon-Peppas,et al.  Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .

[49]  R. Gurny,et al.  pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in Dogs , 1996, Pharmaceutical Research.

[50]  H. Takeuchi,et al.  pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[51]  Dongmei Cun,et al.  Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. , 2007, Journal of pharmaceutical sciences.

[52]  M. Radosz,et al.  pH-responsive nanoparticles for cancer drug delivery. , 2008, Methods in molecular biology.

[53]  H. Junginger,et al.  Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs , 2001, Pharmaceutical Research.

[54]  S. Howell,et al.  Acidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery. , 2007, Bioconjugate chemistry.

[55]  Chi H. Lee,et al.  pH-sensitive Eudragit nanoparticles for mucosal drug delivery. , 2011, International journal of pharmaceutics.

[56]  N. Peppas,et al.  Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[57]  C. H. Goh,et al.  Comparative drug release studies of two cationic drugs from pH-responsive nanogels. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[58]  A. Nokhodchi,et al.  Development of pH-sensitive Insulin Nanoparticles using Eudragit L100-55 and Chitosan with Different Molecular Weights , 2010, AAPS PharmSciTech.

[59]  Hsing-Wen Sung,et al.  A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.

[60]  Mark Voorneveld,et al.  Preparation , 2018, Games Econ. Behav..

[61]  Wei Yang,et al.  Targeted Intestinal Delivery of Supersaturated Itraconazole for Improved Oral Absorption , 2008, Pharmaceutical Research.

[62]  Jiun-Jie Wang,et al.  Self‐Assembled pH‐Sensitive Nanoparticles: A Platform for Oral Delivery of Protein Drugs , 2010 .

[63]  S. Vandermerwe Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs , 2004 .

[64]  Hui Xu,et al.  Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. , 2002, International journal of pharmaceutics.

[65]  K. Tam,et al.  Application of drug selective electrode in the drug release study of pH-responsive microgels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[66]  S. Sajeesh,et al.  Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[67]  R. Gurny,et al.  Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. , 2000, Journal of controlled release : official journal of the Controlled Release Society.